Back to search
FDAFDA · Food and drugs·Recall number D-1027-2018

Valsartan 80 mg tablets, 90-count bottles (NDC 63629-6922-2), 60-count bottles ( 63629-6922-3), 28-count bottles (63629-6922-4), Rx Only, Packaged by Bryant Ranch, Burbank, CA 91504.

Published August 8, 2018 · Recall initiated: July 27, 2018

Summary

FDA records drug Class II recall D-1027-2018, published August 8, 2018 and initiated July 27, 2018. Recalling firm: Bryant Ranch Prepack Inc.; Status: Terminated; Reported quantity: 690 tablets; Lot: Lot # 111158; Exp. 02/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bryant Ranch Prepack Inc.
Distributor
Product was distributed in HI, IN, and FL.
Lot
Lot # 111158; Exp. 02/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan 80 mg tablets, 90-count bottles (NDC 63629-6922-2), 60-count bottles ( 63629-6922-3), 28-count bottles (63629-6922-4), Rx Only, Packaged by Bryant Ranch, Burbank, CA 91504. recalled?

Yes. FDA published recall D-1027-2018 on August 8, 2018. Reported hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter